Positions

Overview

  • Dr. Dransfield is Professor of Medicine and the Director of the Division of Pulmonary, Allergy and Critical Care. He completed his medical degree at the University of North Carolina at Chapel Hill in 1997, followed by residency in internal medicine and fellowship training in pulmonary and critical care medicine at the University of Alabama at Birmingham, where he served as Chief Fellow. He has been on the faculty at UAB since 2003. Dr. Dransfield is also the Ben Branscomb Endowed Chair in Pulmonary Disease and the Medical Director of the UAB Lung Health Center and a member of the both the American Society of Clinical Investigation and Southern Society of Clinical Investigation. Dr. Dransfield's primary clinical interests include chronic obstructive pulmonary disease (COPD) and lung cancer.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2023 Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPDChest.  163:502-514. 2023
    2023 Clinical Implications of Low Absolute Blood Eosinophil Count in the SPIROMICS COPD CohortChest.  163:515-528. 2023
    2023 Roflumilast May Increase Risk of Exacerbations When Used to Treat Poorly Controlled Asthma in People with ObesityAnnals of the American Thoracic Society.  20:206-214. 2023
    2023 Beta-blocker use in patients with chronic obstructive pulmonary disease: A systematic review: A systematic review of βB in COPDTrends in Cardiovascular Medicine.  33:53-61. 2023
    2023 Using Community Health Advisors to Increase Lung Cancer Screening Awareness in the Black Belt: a Pilot StudyJournal of Cancer Education2023
    2022 Acute Exacerbations Are Associated with Progression of EmphysemaAnnals of the American Thoracic Society.  19:2108-2111. 2022
    2022 Effect of chronic mucus hypersecretion on treatment responses to inhaled therapies in patients with chronic obstructive pulmonary disease: Post hoc analysis of the IMPACT trialRespirology.  27:1034-1044. 2022
    2022 Increased chest CT derived bone and muscle measures capture markers of improved morbidity and mortality in COPDRespiratory Research.  23. 2022
    2022 A Randomized Trial of a Nurse-Led Palliative Care Intervention for Patients with Newly Diagnosed Lung CancerJournal of Palliative Medicine.  25:1668-1676. 2022
    2022 Clinical Trial of Losartan for Pulmonary Emphysema: Pulmonary Trials Cooperative Losartan Effects on Emphysema Progression Clinical TrialAmerican Journal of Respiratory and Critical Care Medicine.  206:838-845. 2022
    2022 Lung Function and the Risk of Exacerbation in the β-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease TrialAnnals of the American Thoracic Society.  19:1642-1649. 2022
    2022 Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung FunctionNew England Journal of Medicine.  387:1173-1184. 2022
    2022 Time-Dependent Risk of Cardiovascular Events Following an Exacerbation in Patients With Chronic Obstructive Pulmonary Disease: Post Hoc Analysis From the IMPACT TrialJournal of the American Heart Association.  11. 2022
    2022 Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission 2022
    2022 Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort An Observational Cohort StudyAmerican Journal of Respiratory and Critical Care Medicine.  206:554-562. 2022
    2022 Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine.  206:427-439. 2022
    2022 Comparing Racial Differences in Emphysema Prevalence Among Adults With Normal Spirometry: A Secondary Data Analysis of the CARDIA Lung StudyACP journal club.  175:1118-1125. 2022
    2022 Ambient ozone effects on respiratory outcomes among smokers modified by neighborhood poverty: An analysis of SPIROMICS AIRScience of the Total Environment.  829. 2022
    2022 Quality Standard Position Statements for Health System Policy Changes in Diagnosis and Management of COPD: A Global PerspectiveAdvances in Therapy.  39:2302-2322. 2022
    2022 Identification of Sputum Biomarkers Predictive of Pulmonary Exacerbations in COPDChest.  161:1239-1249. 2022
    2022 Chronotropic index during 6-minute walk and acute respiratory events in COPDGeneRespiratory Medicine.  194. 2022
    2022 Fibrinogen mediates cadmium-induced macrophage activation and serves as a predictor of cadmium exposure in chronic obstructive pulmonary disease 2022
    2022 Longitudinal Association Between Muscle Loss and Mortality in Ever SmokersChest.  161:960-970. 2022
    2022 Prolonged Prone Positioning for COVID-19-induced Acute Respiratory Distress Syndrome: A Randomized Pilot Clinical TrialAnnals of the American Thoracic Society.  19:685-687. 2022
    2022 Reconsidering the Utility of Race-Specific Lung Function Prediction EquationsAmerican Journal of Respiratory and Critical Care Medicine.  205:819-829. 2022
    2022 Cystic Fibrosis Transmembrane Conductance Regulator: Roles in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine.  205:631-640. 2022
    2022 Bronchial Thermoplasty in Patients With Severe Asthma at 5 Years: The Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma StudyChest.  161:614-628. 2022
    2022 Correction to: Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study (Advances in Therapy, (2020), 37, 9, (3775-3790), 10.1007/s12325-020-01409-8)Advances in Therapy.  39:1446. 2022
    2022 Pre-chronic obstructive pulmonary disease: a pathophysiologic process or an opinion term?Current Opinion in Pulmonary Medicine.  28:109-114. 2022
    2022 The Air We Breathe: Respiratory Impact of Indoor Air Quality in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine.  205:378-379. 2022
    2022 Comparative Impact of Depressive Symptoms and FEV1% on Chronic Obstructive Pulmonary DiseaseAnnals of the American Thoracic Society.  19:171-178. 2022
    2022 Neighborhood Socioeconomic Deprivation in Young Adulthood and Future Respiratory Health: The CARDIA Lung StudyAmerican Journal of Medicine.  135:211-218.e1. 2022
    2022 Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre–Chronic Obstructive Pulmonary Disease PatientsAmerican Journal of Respiratory and Critical Care Medicine.  205:275-287. 2022
    2022 Video Telehealth Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease Is Associated with Clinical Improvement Similar to Center-based Pulmonary RehabilitationAnnals of the American Thoracic Society.  19:332-335. 2022
    2022 Characterizing COPD Symptom Variability in the Stable State Utilizing the Evaluating Respiratory Symptoms in COPD InstrumentChronic obstructive pulmonary diseases (Miami, Fla.).  9:195-208. 2022
    2022 Clinically Significant and Comorbid Anxiety and Depression Symptoms Predict Severe Respiratory Exacerbations in Smokers: A Post Hoc Analysis of the COPDGene and SPIROMICS CohortsAnnals of the American Thoracic Society.  19:143-146. 2022
    2022 Heart Rate Variability on 10-Second Electrocardiogram and Risk of Acute Exacerbation of COPD: A Secondary Analysis of the BLOCK COPD TrialChronic obstructive pulmonary diseases (Miami, Fla.).  9:226-236. 2022
    2022 Higher COPD Assessment Test Score Associated With Greater Exacerbations Risk: A Post Hoc Analysis of the IMPACT TrialChronic obstructive pulmonary diseases (Miami, Fla.).  9:68-79. 2022
    2021 Discordant diagnostic criteria for pneumonia in COPD trials: a reviewEuropean Respiratory Review.  30. 2021
    2021 Association between Preserved Ratio Impaired Spirometry and Clinical Outcomes in US AdultsJournal of the American Medical Association.  326:2287-2298. 2021
    2021 Correction to: Classical and lectin complement pathways and markers of inflammation for investigation of susceptibility to infections among healthy older adults (Immunity & Ageing, (2020), 17, 1, (18), 10.1186/s12979-020-00189-7)Immunity and Ageing.  18. 2021
    2021 Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium 2021
    2021 Genetic variation in genes regulating skeletal muscle regeneration and tissue remodelling associated with weight loss in chronic obstructive pulmonary diseaseJournal of Cachexia, Sarcopenia and Muscle.  12:1803-1817. 2021
    2021 InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbationsRespiratory Research.  22. 2021
    2021 Lung microbiota associations with clinical features of COPD in the SPIROMICS cohortnpj Biofilms and Microbiomes.  7. 2021
    2021 The challenge of addressing obesity in people with poorly controlled asthma 2021
    2021 Chronotropic index and acute exacerbations of chronic obstructive pulmonary disease a secondary analysis of block CopdAnnals of the American Thoracic Society.  18:1795-1802. 2021
    2021 Pneumococcal Antibody Function for Immunologic Evaluation: Normal Results in Older Adults, and a Novel Analytical Model for Vaccine ResponseJournal of Clinical Immunology.  41:1964-1968. 2021
    2021 A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trialEuropean Respiratory Journal.  58. 2021
    2021 Pulmonary artery enlargement is associated with exacerbations and mortality in ever-smokers with preserved ratio impaired spirometryAmerican Journal of Respiratory and Critical Care Medicine.  204:481-485. 2021
    2021 Study protocol for a national cohort of adults focused on respiratory health: The American Lung Association Lung Health Cohort (ALA-LHC) StudyBMJ Open.  11. 2021
    2021 Association between Cardiorespiratory Fitness and Bronchiectasis at CT: A Long-term Population-based Study of Healthy Young Adults Aged 18–30 Years in the CARDIA StudyRadiology.  300:190-196. 2021
    2021 Ratio of FEV1/Slow Vital Capacity of < 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung FunctionChest.  160:94-103. 2021
    2021 Binge drinking moderates the association between chronic lung disease and e-cigarette use 2021
    2021 Respiratory exacerbations are associated with muscle loss in current and former smokersThorax.  76:554-560. 2021
    2021 Triple Versus Dual Combination Therapy in Chronic Obstructive Pulmonary Disease in Asian Countries: Analysis of the IMPACT TrialPulmonary Therapy.  7:101-118. 2021
    2021 Risk of exacerbation and pneumonia with single-inhaler triple versus dual therapy in IMPACTAnnals of the American Thoracic Society.  18:788-798. 2021
    2021 COPD: COagulation-associated Pulmonary Disease?Respirology.  26:290-291. 2021
    2021 Urban–Rural Disparities in Deaths from Chronic Lower Respiratory Disease in the United StatesAmerican Journal of Respiratory and Critical Care Medicine.  203:769-772. 2021
    2021 Clinical Development of Mepolizumab for the Treatment of Severe Eosinophilic Asthma: On the Path to Personalized MedicineJournal of Allergy and Clinical Immunology: In Practice.  9:1121-1132.e7. 2021
    2021 Effect of Age on the Efficacy and Safety of Once-Daily Single-Inhaler Triple-Therapy Fluticasone Furoate/Umeclidinium/Vilanterol in Patients With COPD: A Post Hoc Analysis of the Informing the Pathway of COPD Treatment TrialChest.  159:985-995. 2021
    2021 The influence of social support on COPD outcomes mediated by depressionPLoS One.  16. 2021
    2021 Association between inhaled corticosteroids and expiratory central airway collapse in smokersAmerican Journal of Respiratory and Critical Care Medicine.  203:518-521. 2021
    2021 A Patient Charter for Chronic Obstructive Pulmonary DiseaseAdvances in Therapy.  38:11-23. 2021
    2021 Conquest quality standards: For the collaboration on quality improvement initiative for achieving excellence in standards of copd care 2021
    2021 InforMing the PAthway of COPD Treatment (IMPACT Trial) Single-Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/ Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD: Analysis of the Western Europe and North America RegionsChronic obstructive pulmonary diseases (Miami, Fla.).  8:76-90. 2021
    2021 Losartan effects on emphysema progression randomized clinical trial: Rationale, design, recruitment, and retentionChronic obstructive pulmonary diseases (Miami, Fla.).  8:414-426. 2021
    2021 Mucus plugs and emphysema in the pathophysiology of airflow obstruction and hypoxemia in smokersAmerican Journal of Respiratory and Critical Care Medicine.  203:957-968. 2021
    2021 Overlap of genetic risk between interstitial lung abnormalities and idiopathic pulmonary fibrosisAmerican Journal of Respiratory and Critical Care Medicine.  200:1402-1413. 2021
    2021 Polycythemia is associated with lower incidence of severe COPD exacerbations in the SPIROMICS studyChronic obstructive pulmonary diseases (Miami, Fla.).  8:326-335. 2021
    2021 Prognostic value of clinically important deterioration in copd: Impact trial analysisERJ Open Research.  7. 2021
    2021 Thank you all, now onwards and upwards!Chronic obstructive pulmonary diseases (Miami, Fla.).  8:303-305. 2021
    2021 The presence of emphysema on chest imaging and mid-life cognitionERJ Open Research.  7. 2021
    2020 Clinical Phenotypes of Atopy and Asthma in COPD: A Meta-analysis of SPIROMICS and COPDGeneChest.  158:2333-2345. 2020
    2020 Current smoking with or without chronic bronchitis is independently associated with goblet cell hyperplasia in healthy smokers and COPD subjectsScientific Reports.  10. 2020
    2020 Endobronchial coils for emphysema: Dual mechanism of action on lobar residual volume reductionRespirology.  25:1160-1166. 2020
    2020 The effect of inhaled corticosteroid withdrawal and baseline inhaled treatment on exacerbations in the IMPACT study a randomized, double-blind, multicenter clinical trialAmerican Journal of Respiratory and Critical Care Medicine.  202:1237-1243. 2020
    2020 Lung-Specific Risk Factors Associated With Incident Hip Fracture in Current and Former SmokersJournal of Bone and Mineral Research.  35:1952-1961. 2020
    2020 Clinical Investigator Training Program (CITP) – A practical and pragmatic approach to conveying clinical investigator competencies and training to busy cliniciansContemporary Clinical Trials Communications.  19. 2020
    2020 Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease: Benefits and RisksClinics in Chest Medicine.  41:475-484. 2020
    2020 Reply to SuissaAmerican Journal of Respiratory and Critical Care Medicine.  202:773-774. 2020
    2020 Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT StudyAdvances in Therapy.  37:3775-3790. 2020
    2020 Effect of zephyr endobronchial valves on dyspnea, activity levels, and quality of life at one year: Results from a randomized clinical trialAnnals of the American Thoracic Society.  17:829-838. 2020
    2020 End-of-Life Spending and Healthcare Utilization Among Older Adults with Chronic Obstructive Pulmonary DiseaseAmerican Journal of Medicine.  133:817-824.e1. 2020
    2020 Smaller left ventricle size at noncontrast ct is associated with lower mortality in copdgene participantsRadiology.  296:208-215. 2020
    2020 Reduction in all-cause mortality with fluticasone furoate/umeclidinium/vilanterol in patients with chronic obstructive pulmonary diseaseAmerican Journal of Respiratory and Critical Care Medicine.  201:1508-1516. 2020
    2020 Classical and lectin complement pathways and markers of inflammation for investigation of susceptibility to infections among healthy older adultsImmunity and Ageing.  17. 2020
    2020 Classical and lectin complement pathways and markers of inflammation for investigation of susceptibility to infections among healthy older adults.Immunity and Ageing.  17:18. 2020
    2020 Association of Dysanapsis with Chronic Obstructive Pulmonary Disease among Older AdultsJournal of the American Medical Association.  323:2268-2280. 2020
    2020 Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: Results on cardiovascular safety from the IMPACT trialRespiratory Research.  21. 2020
    2020 Acute exacerbations of chronic obstructive pulmonary disease: In search of diagnostic biomarkers and treatable traitsThorax.  75:520-527. 2020
    2020 The effect of exacerbation history on outcomes in the impact trialEuropean Respiratory Journal.  55. 2020
    2020 Heme metabolism genes Downregulated in COPD CachexiaRespiratory Research.  21. 2020
    2020 Predicting Pneumonia in Chronic Obstructive Pulmonary Disease Have We Unraveled the Network of Risks?American Journal of Respiratory and Critical Care Medicine.  201:1026-1027. 2020
    2020 Metoprolol for the Prevention of Exacerbations of COPD. ReplyNew England Journal of Medicine.  382:1375-1376. 2020
    2020 A Qualitative Study of Pulmonary and Palliative Care Clinician Perspectives on Early Palliative Care in Chronic Obstructive Pulmonary DiseaseJournal of Palliative Medicine.  23:513-526. 2020
    2020 Associations Among 25-Hydroxyvitamin D Levels, Lung Function, and Exacerbation Outcomes in COPD: An Analysis of the SPIROMICS CohortChest.  157:856-865. 2020
    2020 Understanding the impact of chronic obstructive pulmonary disease exacerbations on patient health and quality of lifeEuropean Journal of Internal Medicine.  73:1-6. 2020
    2020 Adult Life-Course Trajectories of Lung Function and the Development of Emphysema: The CARDIA Lung StudyAmerican Journal of Medicine.  133:222-230.e11. 2020
    2020 Disease progression modeling in chronic obstructive pulmonary diseaseAmerican Journal of Respiratory and Critical Care Medicine.  201:294-302. 2020
    2020 Exacerbations of chronic obstructive pulmonary disease: time to rename 2020
    2020 Pulmonary artery enlargement and mortality risk in moderate to severe COPD: Results from COPDGeneEuropean Respiratory Journal.  55. 2020
    2020 A risk prediction model for mortality among smokers in the COPDGene® studyChronic obstructive pulmonary diseases (Miami, Fla.).  7:346-361. 2020
    2020 Association of Long-term Ambient Ozone Exposure with Respiratory Morbidity in SmokersJAMA Internal Medicine.  180:106-115. 2020
    2020 Clinical development and research applications of the chronic obstructive pulmonary disease assessment testAmerican Journal of Respiratory and Critical Care Medicine.  201:1058-1067. 2020
    2020 Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS Cohort 2020
    2020 Efficacy and safety of the cftr potentiator icenticaftor (Qbw251) in copd: Results from a phase 2 randomized trial 2020
    2020 Factors influencing decline in quality of life in smokers without airflow obstruction: The COPDGene studyRespiratory Medicine.  161. 2020
    2020 Immunoglobulin E as a biomarker for the overlap of atopic asthma and chronic obstructive pulmonary diseaseChronic obstructive pulmonary diseases (Miami, Fla.).  7:1-12. 2020
    2020 Novel respiratory disability score predicts copd exacerbations and mortality in the spiromics cohort 2020
    2020 Plasma cathelicidin is independently associated with reduced lung function in COPD: Analysis of the subpopulations and intermediate outcome measures in COPD study cohortChronic obstructive pulmonary diseases (Miami, Fla.).  7:370-381. 2020
    2020 Reply to Gagnon et al.American Journal of Respiratory and Critical Care Medicine.  201:120. 2020
    2020 The association between neighborhood socioeconomic disadvantage and chronic obstructive pulmonary disease 2020
    2020 The association of low income and high stress with acute care use in COPD patientsChronic obstructive pulmonary diseases (Miami, Fla.).  7:107-117. 2020
    2019 Metoprolol for the prevention of acute exacerbations of COPDNew England Journal of Medicine.  381:2304-2314. 2019
    2019 COPD exacerbations and MACE: More than a chance encounter?Respirology.  24:1129-1130. 2019
    2019 Reply to moyAmerican Journal of Respiratory and Critical Care Medicine.  200:1443-1444. 2019
    2019 The matrikine acetyl-proline-glycine-proline and clinical features of COPD: Findings from SPIROMICSRespiratory Research.  20. 2019
    2019 Radiographic lung volumes predict progression to COPD in smokers with preserved spirometry in SPIROMICSEuropean Respiratory Journal.  54. 2019
    2019 The St. George's Respiratory Questionnaire Definition of Chronic Bronchitis May Be a Better Predictor of COPD Exacerbations Compared With the Classic DefinitionChest.  156:685-695. 2019
    2019 A genetic risk score associated with chronic obstructive pulmonary disease susceptibility and lung structure on computed tomographyAmerican Journal of Respiratory and Critical Care Medicine.  200:721-731. 2019
    2019 Adherence to Pulmonary Rehabilitation in COPD: A QUALITATIVE EXPLORATION of PATIENT PERSPECTIVES on BARRIERS and FACILITATORSJournal of Cardiopulmonary Rehabilitation and Prevention.  39:344-349. 2019
    2019 Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial 2019
    2019 Misinterpretation of time-to-first event curves can lead to inappropriate treatmentEuropean Respiratory Journal.  54. 2019
    2019 Arterial vascular pruning, right ventricular size, and clinical outcomes in chronic obstructive pulmonary disease a longitudinal observational studyAmerican Journal of Respiratory and Critical Care Medicine.  200:454-461. 2019
    2019 Chronic obstructive pulmonary disease in America's black populationAmerican Journal of Respiratory and Critical Care Medicine.  200:423-430. 2019
    2019 Video telehealth pulmonary rehabilitation intervention in chronic obstructive pulmonary disease reduces 30-day readmissionsAmerican Journal of Respiratory and Critical Care Medicine.  200:511-513. 2019
    2019 A formative evaluation of patient and family caregiver perspectives on early palliative care in chronic obstructive pulmonary disease across disease severityAnnals of the American Thoracic Society.  16:1024-1033. 2019
    2019 Clinical Epidemiology of COPD: Insights From 10 Years of the COPDGene StudyChest.  156:228-238. 2019
    2019 Eosinophil-guided treatment of COPD exacerbations: unfinished business 2019
    2019 The peak index: Spirometry metric for airflow obstruction severity and heterogeneityAnnals of the American Thoracic Society.  16:982-989. 2019
    2019 Lower serum IgA is associated with COPD exacerbation risk in SPIROMICSPLoS One.  13. 2019
    2019 Application of the community health worker model in adult asthma and COPD in the U.S.: A systematic reviewBMC Pulmonary Medicine.  19. 2019
    2019 Discriminative Accuracy of FEV1:FVC Thresholds for COPD-Related Hospitalization and MortalityJournal of the American Medical Association.  321:2438-2447. 2019
    2019 It's more than low BMI: Prevalence of cachexia and associated mortality in COPDRespiratory Research.  20. 2019
    2019 Towards eradication of chronic obstructive pulmonary disease: a Lancet Commission 2019
    2019 Determinants of cigarette smoking status in a national cohort of black and white adult ever smokers in the USA: A cross-sectional analysis of the REGARDS studyBMJ Open.  9. 2019
    2019 Predictors of Response to Endobronchial Coil Therapy in Patients With Advanced EmphysemaChest.  155:928-937. 2019
    2019 Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved Spirometry in SPIROMICSChest.  155:908-917. 2019
    2019 Safety and tolerability of comprehensive research bronchoscopy in chronic obstructive pulmonary disease results from the SPIROMICS bronchoscopy substudyAnnals of the American Thoracic Society.  16:439-446. 2019
    2019 Aspirin Use and Respiratory Morbidity in COPD: A Propensity Score-Matched Analysis in Subpopulations and Intermediate Outcome Measures in COPD StudyChest.  155:519-527. 2019
    2019 Effect of daily azithromycin therapy and adherence on readmission risk in COPDEuropean Respiratory Journal.  53. 2019
    2019 Symptoms of anxiety and depression and use of anxiolytic-hypnotics and antidepressants in current and former smokers with and without COPD - A cross sectional analysis of the COPDGene cohortJournal of Psychosomatic Research.  118:18-26. 2019
    2019 Alignment of inhaled chronic obstructive pulmonary disease therapies with published strategies :analysis of the Global Initiative for Chronic Obstructive Lung Disease recommendations in SpiroMicsAnnals of the American Thoracic Society.  16:200-208. 2019
    2019 Impact of pre-enrolment medication use on clinical outcomes in SUMMITERJ Open Research.  5. 2019
    2019 Reducing chronic obstructive pulmonary disease hospital readmissions: An official American Thoracic Society workshop reportAnnals of the American Thoracic Society.  16:161-170. 2019
    2019 Life-course smoking trajectories and risk for emphysema in middle age: The CARDIA Lung studyAmerican Journal of Respiratory and Critical Care Medicine.  199:237-240. 2019
    2019 Activated PMN Exosomes: Pathogenic Entities Causing Matrix Destruction and Disease in the LungCell.  176:113-126.e15. 2019
    2019 Acquired cystic fibrosis transmembrane conductance regulator dysfunction and radiographic bronchiectasis in current and former smokers: A cross-sectional studyAnnals of the American Thoracic Society.  16:150-153. 2019
    2019 COPDGene® 2019: Redefining the diagnosis of chronic obstructive pulmonary diseaseChronic obstructive pulmonary diseases (Miami, Fla.).  6:384-399. 2019
    2019 Clinical significance of bronchodilator responsiveness evaluated by forced vital capacity in COPD: SPIROMICS cohort analysis 2019
    2019 Combined forced expiratory volume in 1 second and forced vital capacity bronchodilator response, exacerbations, and mortality in chronic obstructive pulmonary diseaseAnnals of the American Thoracic Society.  16:826-835. 2019
    2019 Cost-effectiveness of once-daily single-inhaler triple therapy in COPD: The IMPACT trial 2019
    2019 Inflammation and endothelial activation in early adulthood are associated with future emphysema: The CARDIA Lung StudyEuropean Respiratory Journal.  53. 2019
    2019 Mepolizumab in the treatment of eosinophilic chronic obstructive pulmonary disease 2019
    2019 Velocity transfer function in the right pulmonary artery and impaired cardiopulmonary reserve in COPD 2019
    2018 Centrilobular emphysema and coronary artery calcification: Mediation analysis in the SPIROMICS cohortRespiratory Research.  19. 2018
    2018 Airway fractal dimension predicts respiratory morbidity and mortality in COPDJournal of Clinical Investigation.  128:5374-5382. 2018
    2018 Erratum: Airway fractal dimension predicts respiratory morbidity and mortality in COPD (Journal of Clinical Investigation (2018) 128:12 (5374–5382) DOI: 10.1172/JCI120693)Journal of Clinical Investigation.  128:5676. 2018
    2018 Genomics and response to long-term oxygen therapy in chronic obstructive pulmonary diseaseJournal of Molecular Medicine.  96:1375-1385. 2018
    2018 Longitudinal phenotypes and mortality in preserved ratio impaired spirometry in the COPDGene studyAmerican Journal of Respiratory and Critical Care Medicine.  198:1397-1405. 2018
    2018 Lung function in young adults and risk of cardiovascular events over 29 years: The CARDIA studyJournal of the American Heart Association.  7. 2018
    2018 New Spirometry Indices for Detecting Mild Airflow ObstructionScientific Reports.  8. 2018
    2018 Occupational exposures and computed tomographic imaging characteristics in the SpiromICS cohortAnnals of the American Thoracic Society.  15:1411-1419. 2018
    2018 Unique Lipid Signatures of Extracellular Vesicles from the Airways of AsthmaticsScientific Reports.  8. 2018
    2018 Elevated circulating MMP-9 is linked to increased COPD exacerbation risk in SPIROMICS and COPDGeneJCI Insight.  3. 2018
    2018 Heme scavenging reduces pulmonary endoplasmic reticulum stress, fibrosis, and emphysemaJCI Insight.  3. 2018
    2018 A multicenter randomized controlled trial of Zephyr Endobronchial Valve treatment in heterogeneous emphysema (LIBERATE)American Journal of Respiratory and Critical Care Medicine.  198:1151-1164. 2018
    2018 Interpreting Recent Developments in COPD Treatments 2018
    2018 Interpreting Recent Developments in COPD Treatments. 2018
    2018 Visual Estimate of Coronary Artery Calcium Predicts Cardiovascular Disease in COPDChest.  154:579-587. 2018
    2018 Defining impaired respiratory health a paradigm shift for pulmonary medicineAmerican Journal of Respiratory and Critical Care Medicine.  198:440-446. 2018
    2018 Genome-wide association study of lung function and clinical implication in heavy smokersBMC Medical Genomics.  19. 2018
    2018 Interstitial features at chest CT enhance the deleterious effects of emphysema in the COPDGene cohortRadiology.  288:600-609. 2018
    2018 Exacerbations of chronic obstructive pulmonary disease and cardiac events a post hoc cohort analysis from the SUMMIT randomized clinical trialAmerican Journal of Respiratory and Critical Care Medicine.  198:51-57. 2018
    2018 NT-proBNP in stable COPD and future exacerbation risk: Analysis of the SPIROMICS cohortRespiratory Medicine.  140:87-93. 2018
    2018 Rural residence and chronic obstructive pulmonary disease exacerbations: Analysis of the SPIROMICS cohortAnnals of the American Thoracic Society.  15:808-815. 2018
    2018 Respiratory symptoms in young adults and future lung disease the cardia lung studyAmerican Journal of Respiratory and Critical Care Medicine.  197:1616-1624. 2018
    2018 Anemia and Adverse Outcomes in a Chronic Obstructive Pulmonary Disease Population with a High Burden of Comorbidities. An Analysis from SPIROMICS.Annals of the American Thoracic Society.  15:710-717. 2018
    2018 Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary diseaseJournal of Allergy and Clinical Immunology.  141:2037-2047.e10. 2018
    2018 B-blocker therapy and clinical outcomes in patients with moderate chronic obstructive pulmonary disease and heightened cardiovascular risk an observational substudy of SUMMITAnnals of the American Thoracic Society.  15:608-614. 2018
    2018 Smoking duration alone provides stronger risk estimates of chronic obstructive pulmonary disease than pack-yearsThorax.  73:414-421. 2018
    2018 Paratracheal paraseptal emphysema and expiratory central airway collapse in smokersAnnals of the American Thoracic Society.  15:479-484. 2018
    2018 Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analysesERJ Open Research.  4. 2018
    2018 Simultaneous LC–MS/MS analysis of eicosanoids and related metabolites in human serum, sputum and BALFBiomedical Chromatography.  32. 2018
    2018 Survival of Lung Transplant Candidates With COPD: BODE Score ReconsideredChest.  153:697-701. 2018
    2018 The "Obesity paradox" in chronic obstructive pulmonary disease: Can it be resolved?Annals of the American Thoracic Society.  15:158-159. 2018
    2018 Association of thrombocytosis with COPD morbidity: The SPIROMICS and COPDGene cohortsRespiratory Research.  19. 2018
    2018 CT measurements of central pulmonary vasculature as predictors of severe exacerbation in COPDMedicine.  97. 2018
    2018 Cigarette smoking and response to inhaled corticosteroids in COPDEuropean Respiratory Journal.  51. 2018
    2018 Clinical differences in COPD patients with variable patterns of hypoxemiaChronic obstructive pulmonary diseases (Miami, Fla.).  5:167-178. 2018
    2018 Life-space mobility and clinical outcomes in COPD 2018
    2018 Lobar Emphysema Distribution Is Associated With 5-Year Radiological Disease ProgressionChest.  153:65-76. 2018
    2018 Once-daily single-inhaler triple versus dual therapy in patients with COPDNew England Journal of Medicine.  378:1671-1680. 2018
    2018 Race and gender disparities are evident in COPD underdiagnoses across all severities of measured airflow obstructionChronic obstructive pulmonary diseases (Miami, Fla.).  5:177-184. 2018
    2018 The long-term oxygen treatment trial for chronic obstructive pulmonary disease: Rationale, design, and lessons learnedAnnals of the American Thoracic Society.  15:89-101. 2018
    2018 The use of a standardized order set reduces systemic corticosteroid dose and length of stay for individuals hospitalized with acute exacerbations of COPD: A cohort study 2018
    2017 Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort 2017
    2017 Chest computed tomography-derived low fat-free mass index and mortality in COPDEuropean Respiratory Journal.  50. 2017
    2017 Implications of DRG Classification in a Bundled Payment Initiative for COPD. 2017
    2017 Signs of gas trapping in normal lung density regions in smokersAmerican Journal of Respiratory and Critical Care Medicine.  196:1404-1410. 2017
    2017 Social Determinants of Adherence to Pulmonary Rehabilitation for Chronic Obstructive Pulmonary DiseaseCOPD: Journal of Chronic Obstructive Pulmonary Disease.  14:610-617. 2017
    2017 Inhaled Steroids and Active Smoking Drive Chronic Obstructive Pulmonary Disease Symptoms and Biomarkers to a Greater Degree Than Airflow LimitationBiomarker Insights.  12. 2017
    2017 Computed tomography measure of lung at risk and lung function decline in chronic obstructive pulmonary diseaseAmerican Journal of Respiratory and Critical Care Medicine.  196:569-576. 2017
    2017 Identification of airway mucosal type 2 inflammation by using clinical biomarkers in asthmatic patientsJournal of Allergy and Clinical Immunology.  140:710-719. 2017
    2017 Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort 2017
    2017 Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD)Respiratory Research.  18. 2017
    2017 Measuring nitrate reductase activity from human and rodent tonguesNitric Oxide: Biology and Chemistry.  66:62-70. 2017
    2017 Pulmonary artery to aorta ratio is associated with cardiac structure and functional changes in mild-to-moderate COPD 2017
    2017 Association between cardiorespiratory fitness and lung health from young adulthood to middle agesAmerican Journal of Respiratory and Critical Care Medicine.  195:1236-1243. 2017
    2017 Design of the subpopulations and intermediate outcome measures in COPD (SPIROMICS) AIR studyBMJ Open Respiratory Research.  4. 2017
    2017 Respiratory symptoms items from the COPD assessment test identify ever-smokers with preserved lung function at higher risk for poor respiratory outcomes an analysis of the subpopulations and intermediate outcome measures in COPD Study cohortAnnals of the American Thoracic Society.  14:636-642. 2017
    2017 Results of a Medicare Bundled Payments for care Improvement initiative for chronic obstructive pulmonary disease readmissionsAnnals of the American Thoracic Society.  14:643-648. 2017
    2017 Ventricular Geometry From Non-contrast Non-ECG-gated CT Scans: An Imaging Marker of Cardiopulmonary Disease in SmokersAcademic Radiology.  24:594-602. 2017
    2017 Effect of fluticasone furoate and vilanterol on exacerbations of chronic obstructive pulmonary disease in patients with moderate airflow obstructionAmerican Journal of Respiratory and Critical Care Medicine.  195:881-888. 2017
    2017 Lung Mass in SmokersAcademic Radiology.  24:386-392. 2017
    2017 Gender differences in first and secondhand smoke exposure, spirometric lung function and cardiometabolic health in the old order Amish: A novel population without female smokingPLoS One.  12. 2017
    2017 Sex-based genetic association study identifies celsr1 as a possible chronic obstructive pulmonary disease risk locus among womenAmerican Journal of Respiratory Cell and Molecular Biology.  56:332-341. 2017
    2017 GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery diseaseRespiratory Research.  18. 2017
    2017 Acute exacerbations and lung function loss in smokers with and without chronic obstructive pulmonary diseaseAmerican Journal of Respiratory and Critical Care Medicine.  195:324-330. 2017
    2017 A randomized trial of once-daily fluticasone furoate/vilanterol or vilanterol versus placebo to determine effects on arterial stiffness in COPD 2017
    2017 Biomechanical CT metrics are associated with patient outcomes in COPDThorax.  72:409-414. 2017
    2017 Pulmonary rehabilitation improves outcomes in chronic obstructive pulmonary disease independent of disease burdenAnnals of the American Thoracic Society.  14:26-32. 2017
    2016 Validated and longitudinally stable asthma phenotypes based on cluster analysis of the ADEPT studyRespiratory Research.  17. 2016
    2016 Clinical, physiologic, and radiographic factors contributing to development of hypoxemia in moderate to severe COPD: A cohort studyBMC Pulmonary Medicine.  16. 2016
    2016 CT-derived Biomechanical Metrics Improve Agreement Between Spirometry and EmphysemaAcademic Radiology.  23:1255-1263. 2016
    2016 A ferret model of COPD-related chronic bronchitisJCI Insight.  1. 2016
    2016 Beta-blockers in COPD: Time for reappraisalEuropean Respiratory Journal.  48:880-888. 2016
    2016 Cardiovascular disease in COPD: time to quash a silent killer 2016
    2016 A phase III randomised controlled trial of single-dose triple therapy in COPD: The IMPACT protocolEuropean Respiratory Journal.  48:320-330. 2016
    2016 Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPDPLoS Genetics.  12. 2016
    2016 Pulmonary artery enlargement and cystic fibrosis pulmonary exacerbations: a cohort study 2016
    2016 Association between functional small airway disease and FEV1 decline in chronic obstructive pulmonary diseaseAmerican Journal of Respiratory and Critical Care Medicine.  194:178-184. 2016
    2016 Persistent and newly developed chronic bronchitis are associated with worse outcomes in chronic obstructive pulmonary diseaseAnnals of the American Thoracic Society.  13:1016-1025. 2016
    2016 Meeting the challenge of COPD care delivery in the USA: A multiprovider perspective 2016
    2016 Pilot evaluation of ivacaftor for chronic bronchitis 2016
    2016 β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): A randomised controlled study protocolBMJ Open.  6. 2016
    2016 Effect of endobronchial coils vs usual care on exercise tolerance in patients with severe emphysema: The renew randomized clinical trialJournal of the American Medical Association.  315:2178-2189. 2016
    2016 Pulmonary artery enlargement is associated with cardiac injury during severe exacerbations of COPDChest.  149:1197-1204. 2016
    2016 Serum eosinophils as a COPD biomarker: Ready for prime time? 2016
    2016 Therapeutic approaches to acquired cystic fibrosis transmembrane conductance regulator dysfunction in Chronic bronchitisAnnals of the American Thoracic Society.  13:S169-S176. 2016
    2016 Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Chronic Bronchitis and Other Diseases of Mucus ClearanceClinics in Chest Medicine.  37:147-158. 2016
    2016 Determinants of successful completion of pulmonary rehabilitation in COPD 2016
    2016 Risk factors for COPD exacerbations in inhaled medication users: The COPDGene study biannual longitudinal follow-up prospective cohortBMC Pulmonary Medicine.  16. 2016
    2016 Association between expiratory central airway collapse and respiratory outcomes among smokersJournal of the American Medical Association.  315:498-505. 2016
    2016 Depression is associated with readmission for acute exacerbation of chronic obstructive pulmonary diseaseAnnals of the American Thoracic Society.  13:197-203. 2016
    2016 Differences between absolute and predicted values of forced expiratory volumes to classify ventilatory impairment in chronic obstructive pulmonary diseaseRespiratory Medicine.  111:30-38. 2016
    2016 COPD Overlap Syndromes: Asthma and Beyond.Chronic obstructive pulmonary diseases (Miami, Fla.).  3:459-465. 2016
    2016 Arterial and venous pulmonary vascular morphology and their relationship to findings in cardiac magnetic resonance imaging in smokers 2016
    2016 Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) studyRespiratory Research.  17:1-12. 2016
    2016 Sex-specific features of emphysema among current and former smokers with COPDEuropean Respiratory Journal.  47:104-112. 2016
    2016 β-Blockers are associated with a reduction in COPD exacerbationsThorax.  71:8-14. 2016
    2015 Recovery of acquired cystic fibrosis transmembrane conductance regulator dysfunction after smoking cessationAmerican Journal of Respiratory and Critical Care Medicine.  192:1521-1524. 2015
    2015 Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling studyRespiratory Research.  16. 2015
    2015 Anticholinergic vs long-acting β-Agonist in combination with inhaled corticosteroids in black adults with asthma: The BELT randomized clinical trialJournal of the American Medical Association.  314:1720-1730. 2015
    2015 Benefits of completing pulmonary rehabilitation in patients with asthmaJournal of Asthma.  52:969-973. 2015
    2015 A randomized, placebo-controlled trial of roflumilast effect on proline-glycine-proline and neutrophilic inflammation in chronic obstructive pulmonary diseaseAmerican Journal of Respiratory and Critical Care Medicine.  192:934-942. 2015
    2015 A randomised trial of lung sealant versus medical therapy for advanced emphysemaEuropean Respiratory Journal.  46:651-662. 2015
    2015 Clinical and radiologic disease in smokers with normal spirometryJAMA Internal Medicine.  175:1539-1549. 2015
    2015 Blood eosinophil counts as markers of response to inhaled corticosteroids in COPD? - Authors' reply 2015
    2015 Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: A secondary analysis of data from two parallel randomised controlled trials 2015
    2015 Commentary on "Factors associated with emergency department visits in asthma exacerbation"Southern Medical Journal.  108:281-282. 2015
    2015 Pulmonary artery enlargement is associated with right ventricular dysfunction and loss of blood volume in small pulmonary vessels in chronic obstructive pulmonary diseaseCirculation: Cardiovascular Imaging.  8. 2015
    2015 Executive Summary: Prevention of Acute Exacerbation of COPD: American College of Chest Physicians and Canadian Thoracic Society GuidelineChest.  147:883-893. 2015
    2015 Prevention of Acute Exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society GuidelineChest.  147:894-942. 2015
    2015 IREB2 and GALC are associated with pulmonary artery enlargement in chronic obstructive pulmonary diseaseAmerican Journal of Respiratory Cell and Molecular Biology.  52:365-376. 2015
    2015 Subsets of airway myeloid-derived regulatory cells distinguish mild asthma from chronic obstructive pulmonary diseaseJournal of Allergy and Clinical Immunology.  135:413-424.e15. 2015
    2015 Lung cancer screening, version 1.2015: Featured updates to the NCCN guidelinesJournal of the National Comprehensive Cancer Network : JNCCN.  13:23-34. 2015
    2015 Pneumonia risk with inhaled fluticasone furoate and vilanterol compared with vilanterol alone in patients with COPDAnnals of the American Thoracic Society.  12:27-34. 2015
    2014 Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction: Authors' responseThorax.  69:1147-1148. 2014
    2014 Common genetic variants associated with resting oxygenation in chronic obstructive pulmonary diseaseAmerican Journal of Respiratory Cell and Molecular Biology.  51:678-687. 2014
    2014 Pneumothorax risk factors in smokers with and without chronic obstructive pulmonary diseaseAnnals of the American Thoracic Society.  11:1387-1394. 2014
    2014 Radiological correlates and clinical implications of the paradoxical lung function response to β2 agonists: An observational study 2014
    2014 Cardiovascular disease in COPD: A call for action 2014
    2014 Prediction of acute respiratory disease in current and former smokers with and without COPDChest.  146:941-950. 2014
    2014 Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbationRespiratory Research.  15. 2014
    2014 Genetic susceptibility for chronic bronchitis in chronic obstructive pulmonary diseaseRespiratory Research.  15. 2014
    2014 DNAH5 is associated with total lung capacity in chronic obstructive pulmonary diseaseRespiratory Research.  15. 2014
    2014 Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGeneRespiratory Research.  15. 2014
    2014 Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapyAmerican Journal of Respiratory and Critical Care Medicine.  189:1503-1508. 2014
    2014 Clinical and computed tomographic predictors of chronic bronchitis in COPD: A cross sectional analysis of the COPDGene studyRespiratory Research.  15. 2014
    2014 Computed tomographic measures of airway morphology in smokers and never-smoking normalsJournal of Applied Physiology.  116:668-673. 2014
    2014 Acquired defects in CFTR-dependent β-adrenergic sweat secretion in chronic obstructive pulmonary diseaseRespiratory Research.  15. 2014
    2014 Impact of heterozygote CFTR Mutations in COPD patients with Chronic BronchitisRespiratory Research.  15. 2014
    2014 Pooled subpopulation analyses of the effects of roflumilast on exacerbations and lung function in COPDRespiratory Medicine.  108:366-375. 2014
    2014 Determinants of arterial stiffness in COPDBMC Pulmonary Medicine.  14. 2014
    2014 CT scan-measured pulmonary artery to aorta ratio and echocardiography for detecting pulmonary hypertension in severe COPDChest.  145:824-832. 2014
    2014 Comparison of spirometric thresholds in diagnosing smoking-related airflow obstructionThorax.  69:409-414. 2014
    2014 Cystic fibrosis transmembrane conductance regulator activation by roflumilast contributes to therapeutic benefit in chronic bronchitisAmerican Journal of Respiratory Cell and Molecular Biology.  50:549-558. 2014
    2014 Development and maintenance of a biospecimen repository for clinical samples derived from pulmonary patientsClinical and Translational Science.  7:336-341. 2014
    2014 Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patientsRespiratory Medicine.  108:1171-1179. 2014
    2014 FEV1/FEV6to diagnose airflow obstruction: Comparisons with computed tomography and morbidity indicesAnnals of the American Thoracic Society.  11:335-341. 2014
    2014 Simvastatin for the prevention of exacerbations in moderate-to-severe COPDNew England Journal of Medicine.  370:2201-2210. 2014
    2014 The efficacy of restaging endobronchial ultrasound in patients with non-small cell lung cancer after preoperative therapyAnnals of Thoracic Surgery.  98:1008-1012. 2014
    2014 Tumour necrosis factor receptor-75 and risk of COPD exacerbation in the azithromycin trialEuropean Respiratory Journal.  43:295-298. 2014
    2013 Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator functionAmerican Journal of Respiratory and Critical Care Medicine.  188:1321-1330. 2013
    2013 Sputum PGP is reduced by azithromycin treatment in patients with COPD and correlates with exacerbationsBMJ Open.  3. 2013
    2013 AECOPD: Acute exacerbations of chronic obstructive cardiopulmonary disease?American Journal of Respiratory and Critical Care Medicine.  188:1046-1048. 2013
    2013 Pathophysiology and clinical implications of pulmonary arterial enlargement in COPD 2013
    2013 Heritability of pulmonary function estimated from pedigree and whole-genome markersFrontiers in Genetics.  4. 2013
    2013 Computed tomographic measures of pulmonary vascular morphology in smokers and their clinical implicationsAmerican Journal of Respiratory and Critical Care Medicine.  188:231-239. 2013
    2013 Comparison of spirometric thresholds in diagnosing smoking-related airflow obstructionCOPD: Journal of Chronic Obstructive Pulmonary Disease.  10:400. 2013
    2013 Erratum: Elevated levels of NO are localized to distal airways in asthma (Free Radical Biology and Medicine (2011) 50 (1679-1688))Free Radical Biology and Medicine.  58:45. 2013
    2013 Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: Two replicate double-blind, parallel-group, randomised controlled trials 2013
    2013 GOLD 2011 disease severity classification in COPDGene: A prospective cohort study 2013
    2013 Racial differences in CT phenotypes in COPDCOPD: Journal of Chronic Obstructive Pulmonary Disease.  10:20-27. 2013
    2013 Acquired cystic fibrosis transmembrane conductance regulator dysfunction in the lower airways in COPDChest.  144:498-506. 2013
    2013 Author's reply 2013
    2013 Chronic obstructive pulmonary disease and cardiovascular disease 2013
    2013 Effect of emphysema on CT scan measures of airway dimensions in smokersChest.  143:687-693. 2013
    2012 The authors replyNew England Journal of Medicine.  367:2254-2255. 2012
    2012 Restrictive lung disease: Not restricted to the lung?International Journal of Tuberculosis and Lung Disease.  16:1280. 2012
    2012 Restrictive lung disease: not restricted to the lung? [Editorial].International Journal of Tuberculosis and Lung Disease.  16:1280. 2012
    2012 Pulmonary arterial enlargement and acute exacerbations of COPDNew England Journal of Medicine.  367:913-921. 2012
    2012 Long-term comparative immunogenicity of protein conjugate and free polysaccharide pneumococcal vaccines in chronic obstructive pulmonary diseaseClinical Infectious Diseases.  55. 2012
    2012 Feasibility of exercising adults with asthma: a randomized pilot study 2012
    2012 A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung diseasePLoS One.  7. 2012
    2012 A combined pulmonary-radiology workshop for visual evaluation of COPD: Study design, chest CT findings and concordance with quantitative evaluationCOPD: Journal of Chronic Obstructive Pulmonary Disease.  9:151-159. 2012
    2012 Influence of lightweight ambulatory oxygen on oxygen use and activity patterns of COPD patients receiving long-term oxygen therapyCOPD: Journal of Chronic Obstructive Pulmonary Disease.  9:3-11. 2012
    2012 Lung volume reduction for advanced emphysema: Surgical and bronchoscopic approachesSouthern Medical Journal.  105:56-61. 2012
    2012 Relationship between quantitative CT metrics and health status and BODE in chronic obstructive pulmonary diseaseThorax.  67:399-406. 2012
    2012 Six-minute walk distance predictors, including CT scan measures, in the COPDGene cohortChest.  141:867-875. 2012
    2011 Quantitative CT assessment of emphysema and airways in relation to lung cancer riskRadiology.  261:950-959. 2011
    2011 The clinical features of the overlap between COPD and asthmaRespiratory Research.  12. 2011
    2011 Effect of fluticasone propionate/salmeterol on arterial stiffness in patients with COPDRespiratory Medicine.  105:1322-1330. 2011
    2011 Azithromycin for prevention of exacerbations of COPDNew England Journal of Medicine.  365:689-698. 2011
    2011 Elevated levels of NO are localized to distal airways in asthmaFree Radical Biology and Medicine.  50:1679-1688. 2011
    2011 Disease severity and symptoms among patients receiving monotherapy for COPDPrimary Care Respiratory Journal.  20:46-53. 2011
    2011 Randomized trial of zileuton for treatment of COPD exacerbations requiring hospitalizationCOPD: Journal of Chronic Obstructive Pulmonary Disease.  8:21-29. 2011
    2011 Genome-wide association study of smoking behaviours in patients with COPDThorax.  66:894-902. 2011
    2011 Racial differences in quality of life in patients with COPDChest.  140:1169-1176. 2011
    2011 The relationship between small pulmonary vascular alteration and aortic atherosclerosis in chronic obstructive pulmonary disease. Quantitative CT analysisAcademic Radiology.  18:40-46. 2011
    2010 CT emphysema predicts thoracic aortic calcification in smokers with and without COPDCOPD: Journal of Chronic Obstructive Pulmonary Disease.  7:404-410. 2010
    2010 Determining the optimal pneumococcal vaccination strategy for adults: Is there a role for the pneumococcal conjugate vaccine?Chest.  138:486-490. 2010
    2010 Lung Function in Young Adults Predicts Airflow Obstruction 20 Years LaterAmerican Journal of Medicine.  123. 2010
    2010 Safety and efficacy of an inhaled epidermal growth factor receptor inhibitor (BIBW 2948 BS) in chronic obstructive pulmonary diseaseAmerican Journal of Respiratory and Critical Care Medicine.  181:438-445. 2010
    2010 Biologic lung volume reduction therapy for advanced homogeneous emphysemaEuropean Respiratory Journal.  36:20-27. 2010
    2010 Quantitative CT Measurement of Cross-sectional Area of Small Pulmonary Vessel in COPD. Correlations with Emphysema and Airflow LimitationAcademic Radiology.  17:93-99. 2010
    2010 Quantitative assessment of bronchial wall attenuation with thin-section CT: An indicator of airflow limitation in chronic obstructive pulmonary diseaseAmerican Journal of Roentgenology.  195:363-369. 2010
    2010 The true false negative rates of esophageal and endobronchial ultrasound in the staging of mediastinal lymph nodes in patients with non-small cell lung cancerAnnals of Thoracic Surgery.  90:427-434. 2010
    2009 Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary diseaseAmerican Journal of Respiratory and Critical Care Medicine.  180:499-505. 2009
    2009 Airway wall attenuation: A biomarker of airway disease in subjects with COPDJournal of Applied Physiology.  107:185-191. 2009
    2009 N-α-PGP and PGP, potential biomarkers and therapeutic targets for COPDRespiratory Research.  10. 2009
    2009 Biologic lung volume reduction in advanced upper lobe emphysema phase 2 resultsAmerican Journal of Respiratory and Critical Care Medicine.  179:791-798. 2009
    2009 Racial and sex differences in chronic obstructive pulmonary disease susceptibility, diagnosis, and treatmentCurrent Opinion in Pulmonary Medicine.  15:100-104. 2009
    2009 Sequential comparison of tiotropium to high-dose ipratropium in patients with chronic obstructive pulmonary disease in a practice setting. 2009
    2008 Authors' responseIndian Journal of Medical Research.  63:1026. 2008
    2008 Primary Care of the Patient with Chronic Obstructive Pulmonary Disease-Part 4: Understanding the Clinical Manifestations of a Progressive DiseaseAmerican Journal of Medicine.  121. 2008
    2008 Asthma exacerbations in African Americans treated for 1 year with combination fluticasone propionate and salmeterol or fluticasone propionate aloneCurrent Medical Research and Opinion.  24:1669-1682. 2008
    2008 Use of β blockers and the risk of death in hospitalised patients with acute exacerbations of COPDThorax.  63:301-305. 2008
    2008 Studying COPD in African-Americans: Better late than neverCOPD: Journal of Chronic Obstructive Pulmonary Disease.  5:1-3. 2008
    2008 Authors' responseIndian Journal of Medical Research.  63:1027. 2008
    2008 Pneumococcal vaccination for patients with COPD: Current practice and future directionsChest.  133:767-774. 2008
    2007 Gender differences in the severity of CT emphysema in COPDChest.  132:464-470. 2007
    2006 COPD: Racial Disparities in Susceptibility, Treatment, and OutcomesClinics in Chest Medicine.  27:463-471. 2006
    2006 Racial and gender differences in susceptibility to tobacco smoke among patients with chronic obstructive pulmonary diseaseRespiratory Medicine.  100:1110-1116. 2006
    2006 An unusual cause of chronic cough: Foreign body aspirationJournal of General Internal Medicine.  21. 2006
    2006 Improving the lung cancer resection rate in the US department of Veterans Affairs health systemClinical Lung Cancer.  7:268-272. 2006
    2005 Maintenance pharmacotherapy of chronic obstructive pulmonary disease: An evidence-based approachExpert Opinion on Pharmacotherapy.  6:13-25. 2005
    2004 Fluticasone propionate/salmeterol for the treatment of chronic-obstructive pulmonary diseaseExpert Opinion on Pharmacotherapy.  5:1815-1826. 2004
    2004 Standardized guidelines for surveillance bronchoscopy reduce complications in lung transplant recipientsJournal of Heart and Lung Transplantation.  23:110-114. 2004
    2003 A Mycotic Pulmonary Artery Aneurysm Presenting as an Endobronchial MassChest.  124:1610-1612. 2003

    Research Overview

  • Dr. Dransfield's primary research interest is COPD and he is PI for multiple clinical trials, as well as translational and epidemiological studies, sponsored by the NIH, Department of Defense, American Lung Association, and industry.
  • Principal Investigator On

  • (Spiromics) SubPopulations and InteRmediate Outcome Measures in COPD Study  awarded by WAKE FOREST UNIVERSITY
  • (Spiromics) SubPopulations and InteRmediate Outcome Measures in COPD Study - Administrative Core  awarded by WAKE FOREST UNIVERSITY
  • (Spiromics) SubPopulations and InteRmediate Outcome Measures in COPD Study - Bronchoscopy - Project 1  awarded by WAKE FOREST UNIVERSITY
  • (Spiromics) SubPopulations and InteRmediate Outcome Measures in COPD Study - Exacerbation - Project 2  awarded by WAKE FOREST UNIVERSITY
  • 1/2 Doxycycline for Emphysema in People Living with HIV: The DEPTH Trial  awarded by Cornell University
  • 1/2 Doxycycline for Emphysema in People Living with HIV: The DEPTH Trial (Fixed Price)  awarded by Cornell University
  • ANDDi - American Lung Association Novel Digital Diary Trial  awarded by American Lung Association
  • AZD9688: A First in Class Disease Modifying Therapy to Treat Alpha-1 Antitrypsin Deficiency a Genetically Linked Orphan Disease  awarded by National Center for Advancing Translational Sciences/NIH/DHHS
  • Age Related Differences in Parametrics Response Mapping in COPD (Martinez Supplement)  awarded by University of Michigan
  • Airways Clinical Research Center (ACRC)  awarded by American Lung Association
  • Airways Clinical Research Centers (ACRC)  awarded by American Lung Association
  • Airways Clinical Research Centers (ACRC) Network  awarded by American Lung Association
  • Airways Clinical Research Centers (ACRC) Network  awarded by American Lung Association
  • Airways Clinical Research Centers (ALA-ACRC) Network  awarded by American Lung Association
  • Airways Clinical Research Centers (ALA-ACRC) Network  awarded by American Lung Association
  • Airways Clinical Research Centers (ALA-ACRC) Network  awarded by American Lung Association
  • American Lung Association-Airways Clinical Research Center - Lung Health Cohort  awarded by American Lung Association
  • Asthma BMI Baseline Study (ABBS)  awarded by American Lung Association
  • BI LHC Supplemental Grant: (Boehringer Ingelheim) Lung Health Cohort Supplemental Grant  awarded by American Lung Association
  • Beta Blockers for the Prevention of Acute Exacerbations of COPD  awarded by DOD - ARMY MEDICAL RESEARCH ACQUISITION ACTIVITY
  • COPD Clinical Research Network: STATCOPE Protocol  awarded by University of Minnesota
  • Chronic Refractory Cough Cohort Study (COCO) Trial  awarded by American Lung Association
  • Combined Cardiopulmonary Failure in COPD: SPIROMICS II - HF  awarded by Columbia University
  • Computed Tomographic Characterization of Subjects Enrolled in the STATCOPE Investigation  awarded by Brigham and Women's Hospital
  • Development of a Tuberculosis-Specific Cultural Competency Guide for TB Program Staff Working with Foreign-Born Clients  awarded by SOUTHEASTERN NATIONAL TUBERCULOSIS CENTER
  • Genetic Epidemiology of COPD  awarded by NATIONAL JEWISH MEDICAL RESEARCH CENTER
  • Genetic Epidemiology of Chronic Obstructive Pulmonary Disease  awarded by NATIONAL JEWISH MEDICAL RESEARCH CENTER
  • Impact of Airborne Heavy Metals on Lung Disease and the Environment - Community Engagement Core - Core C  awarded by National Institute of Environmental Health Sciences/NIH/DHHS
  • Improving Medication Adherence with Telehealthcare Medication Therapy Management to Change Health Outcomes in Adolescents and Young Adults with Asthma  awarded by American Lung Association
  • Kit Inhibition in Asthma (KIA)  awarded by Brigham and Women's Hospital
  • Losartan Effects on Emphysema Progression (LEEP) COVID-19 Ancillary Study  awarded by American Lung Association
  • Mucus Microstructure and Osmotic Pressure: Biomarkers for CB in COPD  awarded by Johns Hopkins University
  • Network Management Core (NEMO) for the Pulmonary Trials Cooperative (PTC) (RETHINC)  awarded by COPD FOUNDATION
  • Network Management Core (NEMO) for the Pulmonary Trials Cooperative (PTC) (RETHINC)  awarded by COPD FOUNDATION
  • Network Management Core (NEMO) for the Pulmonary Trials Cooperative (PTC) INSIGHT (Intervention Study in Overweight Patients with COPD)  awarded by University of Pittsburgh The
  • Network Management Core (NEMO) for the Pulmonary Trials Cooperative (PTC) LEEP (Losartan Effects on Emphysema Progression) Trial  awarded by American Lung Association
  • Network Management Cote (NEMO) for the Pulmonary Trials Cooperative (PTC) (INSIGHT)  awarded by COPD FOUNDATION
  • Pharmacogenomics of Inhaled Corticosteroids to Reduce COPD Exacerbations  awarded by Brigham and Women's Hospital
  • Private Grant  awarded by GlaxoSmithKline
  • Private Grant  awarded by ALLEGRO DIAGNOSTICS, INC.
  • Private Grant  awarded by GlaxoSmithKline
  • Private Grant  awarded by BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. ^
  • Private Grant  awarded by GlaxoSmithKline
  • Private Grant  awarded by BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. ^
  • Private Grant  awarded by GlaxoSmithKline
  • Private Grant  awarded by BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. ^
  • Private Grant  awarded by GlaxoSmithKline
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC
  • Private Grant  awarded by GlaxoSmithKline
  • Private Grant  awarded by GlaxoSmithKline
  • Private Grant  awarded by BOSTON SCIENTIFIC CORPORATION
  • Private Grant  awarded by OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC
  • Private Grant  awarded by GlaxoSmithKline
  • Private Grant  awarded by MedImmune
  • Private Grant  awarded by OLMSTED MEDICAL CENTER
  • Private Grant  awarded by GlaxoSmithKline
  • Private Grant  awarded by Pfizer Pharmaceuticals
  • Private Grant  awarded by AERIS THERAPEUTICS, INC.
  • Private Grant  awarded by BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. ^
  • Private Grant  awarded by GlaxoSmithKline
  • Private Grant  awarded by PULMONX
  • Private Grant  awarded by PEARL THERAPEUTICS
  • Private Grant  awarded by PEARL THERAPEUTICS
  • Private Grant  awarded by PNEUMRX, INC.
  • Private Grant  awarded by GlaxoSmithKline
  • Private Grant  awarded by ASTRAZENECA PHARMACEUTICALS LP
  • Private Grant  awarded by YUNGJIN PHARM. CO.,LTD.
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION
  • Private Grant  awarded by PNEUMRX, INC.
  • Private Grant  awarded by BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. ^
  • Private Grant  awarded by PNEUMRX, INC.
  • Private Grant  awarded by GlaxoSmithKline
  • Private Grant  awarded by MEREO BIOPHARMA 4 LIMITED
  • Private Grant  awarded by GALA THERAPEUTICS INC
  • Private Grant  awarded by NUVAIRA INC
  • Private Grant  awarded by PULMONX
  • Prostaglandin Inhibition for Emphysema  awarded by UNIVERSITY OF NEBRASKA
  • Reliability of a Portable Device to Measure Respiratory and Step Rates  awarded by UNIVERSITY OF NEBRASKA
  • Reliability of a Portable Device to Measure Respiratory and Step Rates  awarded by UNIVERSITY OF NEBRASKA, OMAHA
  • SPIROMICS GIC Support  awarded by University of North Carolina at Chapel Hill
  • SPIROMICS II: Biological Underpinnings of COPD Heterogeneity and Progression  awarded by University of California, San Francisco
  • Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)  awarded by COPD FOUNDATION
  • Symbicort in HRCT-Defined Airway Predominant COPD  awarded by NATIONAL JEWISH MEDICAL RESEARCH CENTER
  • The American Lung Association (ALA) Lung Health Cohort  awarded by Northwestern University
  • The Association of Allergic Disease with Clinical Outcomes in COPD  awarded by Johns Hopkins University
  • Trial of Roflumilast in Asthma Management (TRIM) Study  awarded by American Lung Association
  • UAB CF Research and Translation Core Center - A Multicenter Randomized, Double-blind, Phase 2, Placebo Controlled Study to Determine the Safety and Efficacy of Ivacaftor (VX-770) for the Treatment of Chronic Obstructive Pulmonary Disease (The Multicenter Topic Trial).  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
  • UAB Mentoring Program In COPD Patient Oriented Research  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS
  • UAB/BVAMC Clinical Center in COPD  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS
  • Understanding the Origins of Early COPD  awarded by Weill (Joan and Sanford I.) Medical College of Cornell University
  • Investigator On

  • 1/2 Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease (Tele-COPD)  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS
  • A Novel Exosomal Inflammatory Pathway  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS
  • A Pilot Study of the Effect of the CFTR Potentiator Ivacaftor in COPD (P-Topic)  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS
  • A Retrospective Study of Clinical Outcomes in COPD Patients with COVID-19  awarded by Temple University
  • Acquired Deficiency of Innate Immunity (Ficolin-2) Among Elderly Adults  awarded by National Institute on Aging/NIH/DHHS
  • Acquired LTA4H Dysfunction in COPD  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS
  • Asthma Cohort Support Contract  awarded by National Institute of Child Health and Human Development/NIH/DHHS
  • COPD Get With it Program: Exercise Intervention to Reduce Hospital Readmissions  awarded by UNIVERSITY OF ALABAMA HEALTH SERVICES FOUNDATION
  • Collaborative Cohort of Cohorts for COVID Research (C4R)  awarded by Columbia University
  • Diastolic Dysfunction and Pauci-inflammatory Acute Exacerbations of Chronic Obstructive Pulmonary Disease  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS
  • Differentiation of Regulatory Myeloid-Derived Cells by Reactive Oxygen Species  awarded by PARKER B. FRANCIS FOUNDATION
  • Evaluation of the Relationship Between Daytime Activity and Sleep on Asthma Symptoms in Pregnant Asthmatic Patients (B Well Mom Ancillary Study)  awarded by Northwestern University
  • Fibroblast Growth Factor 23/Klotho Crosstalk and Airway Epithelial Senescence in COPD  awarded by National Institute on Aging/NIH/DHHS
  • HL-A New Pathway for Neutrophil-Induced Airway Inflammation  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS
  • Impact of Airborne Heavy Metals on Lung Disease and the Environment  awarded by National Institute of Environmental Health Sciences/NIH/DHHS
  • Impaired Pneumococcal Antibody Function and Exacerbations of Chronic Obstructive Pulmonary Disease  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS
  • Integrating Genomic Risk Assessment for Chronic Disease Management in a Diverse Population  awarded by National Human Genome Research Institute/NIH/DHHS
  • LOTT Regional Clinical Centers  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS
  • Long Term Oxygen Treatment Trial (LOTT) Pharmacogenomics Ancillary Study  awarded by Brigham and Women's Hospital
  • Lung Function Decline and Disease Risk from Young Adulthood to Middle Age  awarded by Northwestern University
  • Molecular Pathogenesis and Phenotype of Acquired CFTR Dysfunction in COPD  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS
  • Molecular Pathogenesis and Phenotype of Acquired CFTR Dysfunction in COPD  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS
  • Network Medicine Approaches to Cachexia in COPD  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS
  • PGP: A Possible Biomarker for COPD Exacerbations/ Progression  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS
  • Prevalence and Implications of Diastolic Dysfunction in Acute Exacerbations of Chronic Obstructive Pulmonary Disease  awarded by American Heart Association
  • Private Grant  awarded by FOREST LABORATORIES, INC.
  • Private Grant  awarded by FOREST RESEARCH INSTITUTE, INC.
  • Private Grant  awarded by GlaxoSmithKline
  • Private Grant  awarded by GlaxoSmithKline
  • Private Grant  awarded by VERTEX PHARMACEUTICALS, INC.
  • Private Grant  awarded by GlaxoSmithKline
  • Private Grant  awarded by ASTRAZENECA PHARMACEUTICALS LP
  • Private Grant  awarded by VERACYTE, INC.
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION
  • Private Grant  awarded by PROTERIXBIO, INC.
  • Private Grant  awarded by VERTEX PHARMACEUTICALS, INC.
  • Private Grant  awarded by GlaxoSmithKline
  • Private Grant  awarded by Bayer AG
  • Private Grant  awarded by GlaxoSmithKline
  • Private Grant  awarded by PEARL THERAPEUTICS
  • Private Grant  awarded by ASTRAZENECA PHARMACEUTICALS LP
  • Private Grant  awarded by MEREO BIOPHARMA 4 LIMITED
  • Private Grant  awarded by ARCUS-MED LLC
  • Private Grant  awarded by NUVAIRA INC
  • Private Grant  awarded by GALA THERAPEUTICS INC
  • Private Grant  awarded by MERCK SHARP & DOHME CORP
  • Roflumilast or Azithromycin to Prevent COPD Exacerbation (RELIANCE)  awarded by UNIVERSITY OF ILLINOIS (CHICAGO)
  • Second-Hand Smoke and Myeloid Cells in Asthma  awarded by Flight Attendant Medical Research Institute
  • Silent Zones of Lung Disease in COPD  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS
  • Training Program in Lung Biology and Translational Medicine  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS
  • Training Program in Lung Biology and Translational Medicine  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS
  • Transitions from Impaired Respiratory Health to Lung Disease (UAB)  awarded by Northwestern University
  • Translational Program in CFTR-Related Airway Diseases  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS
  • UAB CF Research and Translation Core Center  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
  • UAB Lung Imaging Core  awarded by UNIVERSITY OF ALABAMA HEALTH SERVICES FOUNDATION
  • Education And Training

  • UAB Hospital, Internship
  • UAB Hospital, Residency
  • UAB Hospital, Postdoctoral Fellowship
  • Doctor of Medicine, University of North Carolina System : Chapel Hill 1997
  • Full Name

  • Mark Dransfield